Market Value1,402,501,000
Total Holdings49
File Date2020-11-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
KYMR / Kymera Therapeutics, Inc.
RLAY / Relay Therapeutics, Inc.
GERN / Geron Corporation
VINC / Vincerx Pharma, Inc.
FATE / Fate Therapeutics, Inc.
AMTI / Applied Molecular Transport Inc.
MORF / Morphic Holding, Inc.
DRNA / Dicerna Pharmaceuticals Inc
PRTA / Prothena Corporation plc
CMAX / CareMax, Inc.
NLTX / Neoleukin Therapeutics, Inc.
CRVS / Corvus Pharmaceuticals, Inc.
NRIX / Nurix Therapeutics, Inc.
BCEL / Atreca, Inc.
IRWD / Ironwood Pharmaceuticals, Inc. Call
MTCR / Metacrine Inc
US38341PAA03 / Gossamer Bio Inc
EQ / Equillium, Inc.
KLDO / Kaleido Biosciences, Inc.
PLRX / Pliant Therapeutics, Inc.
RLMD / Relmada Therapeutics, Inc.
US74140Y1010 / Prevail Therapeutics Inc.
XOMA / XOMA Royalty Corporation
110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
GMTX / Gemini Therapeutics Inc
RPRX / Royalty Pharma plc
MGTX / MeiraGTx Holdings plc
US33830X1046 / Five Prime Therapeutics Inc
STRO / Sutro Biopharma, Inc.
FULC / Fulcrum Therapeutics, Inc.
AKUS / Akouos Inc
US2103731061 / Constellation Pharmaceuticals Inc
US2103731061 / Constellation Pharmaceuticals Inc Call
DNLI / Denali Therapeutics Inc.
ICPT / Intercept Pharmaceuticals Inc Call
ANAB / AnaptysBio, Inc.
TNGX / Tango Therapeutics, Inc.
EVLO / Evelo Biosciences, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
ALPN / Alpine Immune Sciences, Inc.
RCUS / Arcus Biosciences, Inc.
MGTA / Magenta Therapeutics Inc
XCUR / Exicure, Inc.
SVRA / Savara Inc.
ASMB / Assembly Biosciences, Inc.
ASMB / Assembly Biosciences, Inc. Call
SURF / Surface Oncology Inc
RPTX / Repare Therapeutics Inc.
UBX / Unity Biotechnology, Inc.
ACRS / Aclaris Therapeutics, Inc.
GLYC / GlycoMimetics, Inc.
GLYC / GlycoMimetics, Inc. Call
MRTX / Mirati Therapeutics, Inc.
HSAQ / Health Sciences Acquisitions Corp 2
CYCN / Cyclerion Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
NUVB / Nuvation Bio Inc.
ITOS / iTeos Therapeutics, Inc.
ALVR / AlloVir, Inc.
PMVP / PMV Pharmaceuticals, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
DYN / Dyne Therapeutics, Inc.
KROS / Keros Therapeutics, Inc.
KURA / Kura Oncology, Inc.
XNCR / Xencor, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
RNA / Avidity Biosciences, Inc.